NOAH CHANCE: Open Payments
NPI 1831663442 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
| Exact Sciences Corporation | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Dexcom G6 Transmitter, Wegovy, Cologuard Collection Kit, Symbravo, MOUNJARO, JARDIANCE, Ozempic.
Industry payments across ID — which companies pay providers there.
